{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:48Z","timestamp":1792834728189,"version":"4.5.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Small cell lung cancer (SCLC) is a highly aggressive malignancy. It typically advances quickly, spreads distantly at an early stage, and carries a dismal prognosis, factors that collectively present formidable obstacles to effective treatment. To date, evidence regarding the effectiveness of traditional Chinese medicine (TCM) used alone in extensive-stage SCLC remains sparse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 79-year-old man presented with a persistent cough, exertional shortness of breath, hemoptysis with pale-red sticky sputum, and a headache localized to the right forehead, accompanied by difficulty sleeping at night.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Imaging and histopathology confirmed extensive-stage SCLC with right frontal lobe metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient refused chemotherapy\/immunotherapy and received individualized TCM treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Serial imaging showed a partial response; symptoms markedly resolved; overall survival reached 15.5 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>While findings from a single case must be interpreted cautiously, this experience suggests TCM might contribute to improved outcomes in select patients with extensive-stage SCLC. Further research is needed to clarify its biological mechanisms and define its potential role in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050396","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:01:01Z","timestamp":1787968861000},"page":"e50396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Traditional Chinese medicine monotherapy in extensive-stage small cell lung cancer"],"prefix":"10.1097","volume":"105","author":[{"given":"Xinyu","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3836-7779","authenticated-orcid":false,"given":"Shaoquan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol"},{"key":"R2-20261024","first-page":"620","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions.","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-019-0736-3","article-title":"Emerging therapies for small cell lung cancer.","volume":"12","author":"Yang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41598-017-01571-0","article-title":"Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages.","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.3390\/ijms25084208","article-title":"Transitioning to a personalized approach in molecularly subtyped small-cell lung cancer (SCLC).","volume":"25","author":"Grenda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11864-024-01268-3","article-title":"Tarlatamab-dlle: a new hope for patients with extensive-stage small-cell lung cancer.","volume":"25","author":"Goyal","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","article-title":"Phase III trial of irinotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.","volume":"27","author":"Lara","year":"2009","journal-title":"J Clin Oncol"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2011.40.4905","article-title":"Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.","volume":"30","author":"Rossi","year":"2012","journal-title":"J Clin Oncol"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer.","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"113581","DOI":"10.1016\/j.ejca.2024.113581","article-title":"Recent advances and future strategies in first-line treatment of ES-SCLC.","volume":"200","author":"Gomez-Randulfe","year":"2024","journal-title":"Eur J Cancer"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"e2317790121","DOI":"10.1073\/pnas.2317790121","article-title":"EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.","volume":"121","author":"Yang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.21037\/tlcr-21-691","article-title":"Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment.","volume":"10","author":"Hwang","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.21037\/tlcr.2020.01.07","article-title":"Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report.","volume":"9","author":"Ma","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12957-020-02004-5","article-title":"Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.","volume":"18","author":"Chen","year":"2020","journal-title":"World J Surg Oncol"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00428-024-03754-3","article-title":"Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer.","volume":"486","author":"Zhu","year":"2025","journal-title":"Virchows Arch"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"100883","DOI":"10.1016\/j.tranon.2020.100883","article-title":"Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression.","volume":"14","author":"Vitorino","year":"2021","journal-title":"Transl Oncol"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1097\/CM9.0000000000001141","article-title":"Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer.","volume":"133","author":"Su","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","article-title":"Traditional Chinese medicine in lung cancer treatment.","volume":"24","author":"Xi","year":"2025","journal-title":"Mol Cancer"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","article-title":"Emerging strategies for the treatment of small cell lung cancer: a review.","volume":"9","author":"Petty","year":"2023","journal-title":"JAMA Oncol"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/1078-0432.CCR-23-3087","article-title":"In search of lost biomarker for immunotherapy in small cell lung cancer.","volume":"30","author":"Rolfo","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"R24-20261024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer.","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate.","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2014.02.031","article-title":"Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.","volume":"156","author":"McFadden","year":"2014","journal-title":"Cell"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1084\/jem.20181155","article-title":"Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells.","volume":"216","author":"Chen","year":"2019","journal-title":"J Exp Med"},{"key":"R28-20261024","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1541-7786.MCR-13-0554","article-title":"PTEN is a potent suppressor of small cell lung cancer.","volume":"12","author":"Cui","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"114248","DOI":"10.1016\/j.biopha.2023.114248","article-title":"Targeting the notch signaling pathway and the notch ligand, DLL3, in small cell lung cancer.","volume":"159","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R30-20261024","doi-asserted-by":"crossref","first-page":"e1005895","DOI":"10.1371\/journal.pgen.1005895","article-title":"Genomic landscape survey identifies SRSF1 as a key oncodriver in small cell lung cancer.","volume":"12","author":"Jiang","year":"2016","journal-title":"PLoS Genet"},{"key":"R31-20261024","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1200\/JCO.22.02823","article-title":"Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: an open-label, phase I study.","volume":"41","author":"Paz-Ares","year":"2023","journal-title":"J Clin Oncol"},{"key":"R32-20261024","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1158\/1078-0432.CCR-19-1133","article-title":"Efficacy and safety of rovalpituzumab tesirine in third-line and beyond patients with DLL3-expressing, relapsed\/refractory small-cell lung cancer: results from the phase II TRINITY study.","volume":"25","author":"Morgensztern","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R33-20261024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-019-0745-2","article-title":"DLL3: an emerging target in small cell lung cancer.","volume":"12","author":"Owen","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R34-20261024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1470-2045(16)30565-4","article-title":"Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.","volume":"18","author":"Rudin","year":"2017","journal-title":"Lancet Oncol"},{"key":"R35-20261024","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/2159-8290.CD-19-0582","article-title":"Combination olaparib and temozolomide in relapsed small-cell lung cancer.","volume":"9","author":"Farago","year":"2019","journal-title":"Cancer Discov"},{"key":"R36-20261024","doi-asserted-by":"crossref","first-page":"115748","DOI":"10.1016\/j.jep.2022.115748","article-title":"Traditional Chinese medicine has great potential as candidate drugs for lung cancer: a review.","volume":"300","author":"Wei","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R37-20261024","first-page":"2103","article-title":"Effects of shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis.","volume":"26","author":"Duan","year":"2018","journal-title":"Support Care Cancer"},{"key":"R38-20261024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ctim.2015.12.006","article-title":"Traditional Chinese medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: a randomized controlled trial.","volume":"24","author":"Jiang","year":"2016","journal-title":"Complement Ther Med"},{"key":"R39-20261024","first-page":"3545","article-title":"Homoisoflavanone-1 isolated from polygonatum odoratum arrests the cell cycle and induces apoptosis in A549 cells.","volume":"16","author":"Ning","year":"2018","journal-title":"Oncol Lett"},{"key":"R40-20261024","doi-asserted-by":"crossref","first-page":"156278","DOI":"10.1016\/j.phymed.2024.156278","article-title":"Casticin inhibits proliferation of non-small cell lung cancer cells through regulating reprogramming of glucose metabolism.","volume":"136","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"key":"R41-20261024","doi-asserted-by":"crossref","first-page":"110746","DOI":"10.1016\/j.cellsig.2023.110746","article-title":"Bufalin inhibits the proliferation of lung cancer cells by suppressing hippo-YAP pathway.","volume":"109","author":"Qian","year":"2023","journal-title":"Cell Signal"},{"key":"R42-20261024","doi-asserted-by":"crossref","first-page":"155099","DOI":"10.1016\/j.phymed.2023.155099","article-title":"Modulation of cellular metabolism and alleviation of bacterial dysbiosis by aconiti lateralis radix praeparata in non-small cell lung cancer treatment.","volume":"126","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"R43-20261024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10020-024-00813-y","article-title":"Ginsenoside RH2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-\u03b1\/PDK4 axis in non-small cell lung cancer.","volume":"30","author":"Liu","year":"2024","journal-title":"Mol Med"},{"key":"R44-20261024","doi-asserted-by":"crossref","first-page":"155090","DOI":"10.1016\/j.phymed.2023.155090","article-title":"Kaempferol promotes non-small cell lung cancer cell autophagy via restricting met pathway.","volume":"121","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"R45-20261024","doi-asserted-by":"crossref","first-page":"e13402","DOI":"10.1111\/cpr.13402","article-title":"The sodium new houttuyfonate suppresses NSCLC via activating pyroptosis through TCONS-14036\/miR-1228-5p\/PRKCDBP pathway.","volume":"56","author":"Jiang","year":"2023","journal-title":"Cell Prolif"},{"key":"R46-20261024","doi-asserted-by":"crossref","first-page":"154601","DOI":"10.1016\/j.phymed.2022.154601","article-title":"Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction.","volume":"109","author":"Jiaqi","year":"2023","journal-title":"Phytomedicine"},{"key":"R47-20261024","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijbiomac.2020.09.227","article-title":"Effects of WSG, a polysaccharide from ganoderma lucidum, on suppressing cell growth and mobility of lung cancer.","volume":"165","author":"Hsu","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"R48-20261024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/onc.2016.195","article-title":"The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.","volume":"36","author":"Chiu","year":"2017","journal-title":"Oncogene"},{"key":"R49-20261024","doi-asserted-by":"crossref","first-page":"4010797","DOI":"10.1155\/2023\/4010797","article-title":"Inhibitory effect of astragalus polysaccharide on premetastatic niche of lung cancer through the S1PR1-STAT3 signaling pathway.","volume":"2023","author":"Shen","year":"2023","journal-title":"Evid Based Complement Alternat Med"},{"key":"R50-20261024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3892\/or.2016.5296","article-title":"Delphinidin inhibits angiogenesis through the suppression of HIF-1\u03b1 and VEGF expression in A549 lung cancer cells.","volume":"37","author":"Kim","year":"2017","journal-title":"Oncol Rep"},{"key":"R51-20261024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/cmi.2011.12","article-title":"Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.","volume":"8","author":"Cai","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"R52-20261024","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.1002\/cam4.5960","article-title":"Ginsenoside RH2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p\/STK4 axis and inactivating wnt\/\u03b2-catenin signaling.","volume":"12","author":"Ma","year":"2023","journal-title":"Cancer Med"},{"key":"R53-20261024","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1039\/D1FO00643F","article-title":"RH2-enriched Korean ginseng (ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer.","volume":"12","author":"Lev-Ari","year":"2021","journal-title":"Food Funct"},{"key":"R54-20261024","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12011-014-0056-y","article-title":"The effect of selenium and polysaccharide of atractylodes macrocephala koidz. (PAMK) on immune response in chicken spleen under heat stress.","volume":"160","author":"Xu","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"R55-20261024","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/D1FO03630K","article-title":"Sulfated Chinese yam polysaccharide enhances the immunomodulatory activity of RAW 264.7 cells via the TLR4-MAPK\/NF-\u03baB signaling pathway.","volume":"13","author":"Liu","year":"2022","journal-title":"Food Funct"},{"key":"R56-20261024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","article-title":"Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer.","volume":"68","author":"Li","year":"2025","journal-title":"J Adv Res"},{"key":"R57-20261024","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/biom10111532","article-title":"Magnoflorine-isolation and the anticancer potential against NCI-H1299 lung, MDA-MB-468 breast, T98G glioma, and TE671 rhabdomyosarcoma cancer cells.","volume":"10","author":"Okon","year":"2020","journal-title":"Biomolecules"},{"key":"R58-20261024","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jpp\/rgaa065","article-title":"Jatrorrhizine: a review of its pharmacological effects.","volume":"73","author":"Rolle","year":"2021","journal-title":"J Pharm Pharmacol"},{"key":"R59-20261024","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2004.12.044","article-title":"Involvement of Bcl-2 family, cytochrome and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells.","volume":"230","author":"Lin","year":"2005","journal-title":"Cancer Lett"},{"key":"R60-20261024","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3390\/molecules27092946","article-title":"Atractylodin induces apoptosis and inhibits the migration of A549 lung cancer cells by regulating ROS-mediated signaling pathways.","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:01:35Z","timestamp":1792832495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050396"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":60,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050396","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}